Viewing nowCombinationTrinwon Tablets 80/5/5 mg
Telmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Dae Won Pharmaceutical Co., Ltd.

MFDS item code 201802228 · Approved 2018.05.30 · Insurance code 671806630
Treatment of hypertension and dyslipidemia; inhibition of atherosclerosis progression and reduction of cardiovascular disease risk
This medication is used for hypertensive patients whose blood pressure is not well controlled with Telmisartan and Amlodipine combination therapy, and for patients requiring administration of Rosuvastatin. The Telmisartan/Amlodipine combination improves blood pressure in patients with essential hypertension, and Rosuvastatin helps treat various lipid disorders, including hypercholesterolemia and familial hypercholesterolemia. Additionally, Rosuvastatin is useful in slowing the progression of atherosclerosis and reducing the risk of stroke, myocardial infarction, and vascular revascularization in certain high-risk cardiovascular patients. Thus, this medication is used to effectively manage hypertension and dyslipidemia, improving cardiovascular health.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking telmisartan/amlodipine combination therapy together with rosuvastatin as a single agent, they may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended that the dose of the individual components (amlodipine or telmisartan) be adjusted. However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, regardless of meals. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient for most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg once daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients. In a drug interaction study of the active ingredients of this medicine, telmisartan/amlodipine 80/10 mg and rosuvastatin 20 mg, rosuvastatin Cmax increased approximately 2.4-fold and AUC approximately 1.3-fold in the presence of telmisartan/amlodipine. Therefore, when administering this medicine, assess the potential risk due to the increase in rosuvastatin Cmax and monitor the patient closely.
This medication must not be used during pregnancy. If pregnancy is confirmed, discontinue this medication immediately, and women who may become pregnant should use appropriate contraceptive methods. This medication should not be administered to patients who are allergic to the active ingredient or other components or who have certain diseases. For example, patients with a history of angioedema, severe liver impairment, severe kidney impairment, severe aortic stenosis, or severe myopathy should not take this medication. Elderly patients, patients with hypotension, patients with hyperkalemia, and patients with poor liver function should use this medication cautiously, and periodic blood tests and physical condition checks are necessary during use. This medication may cause muscle-related adverse reactions such as myalgia or muscle weakness, and in severe cases, rhabdomyolysis; therefore, if symptoms of muscle pain or weakness occur, consult a doctor immediately. Additionally, this medication can affect liver function; thus, liver enzyme levels should be checked regularly before and during treatment, and if there is a significant increase in liver enzyme levels, discontinue use. This medication can interact with other medications; therefore, if other medications are being taken, it is essential to inform a physician or pharmacist, especially caution is needed when taken with antihypertensives, diuretics, potassium supplements, immunosuppressants, certain antibiotics, and fibrate medications. Women who are breastfeeding are advised not to take this medication, and if it is necessary to take it, breastfeeding should be discontinued. This medication is not recommended for children and adolescents under 18 years of age as its safety and efficacy have not been sufficiently established. In case of overdose, symptoms such as hypotension, dizziness, and renal function abnormalities may appear, thus seeking appropriate medical treatment immediately is necessary. While taking this medication, caution should be exercised while driving or operating hazardous machinery, as dizziness or drowsiness may occur.
Viral upper respiratory infection, respiratory distress, rectal bleeding, dyspepsia, atopic dermatitis, peripheral edema, chronic gastritis, various gastrointestinal disorders, hiatal hernia, infections, fungal infections, abscesses, otitis media, erectile dysfunction, low back pain, sinusitis, diarrhea, pharyngitis, allergies, fever, leg pain, fatigue, palpitations, dependent edema, angina, rapid pulse, leg edema, abnormal ECG, insomnia, drowsiness, migraine, dizziness, sensory abnormalities, involuntary muscle contractions, sensory loss, flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, non-specific gastrointestinal diseases, gout, hypercholesterolemia, diabetes, arthritis, arthralgia, leg numbness, anxiety, depression, irritability, asthma, bronchitis, rhinitis, nosebleeds, dermatitis, rash, eczema, pruritis, frequent urination, cystitis, cerebrovascular diseases, visual disturbances, conjunctivitis, tinnitus, ear pain, vascular edema, hypersensitivity reactions, increased sweating, erythema, chest pain, atrial fibrillation, congestive heart failure, myocardial infarction, hypertension, worsening of hypertension, hypotension, hyperkalemia, hypoglycemia, syncope, urinary tract infections, muscle cramps, myalgia, bradycardia, eosinophilia, thrombocytopenia, increase in uric acid, abnormal liver function, liver disease, acute renal failure, anemia, elevated CPK, anaphylactic reaction, tendon pain, rhabdomyolysis, vasculitis, peripheral neuropathy, tremors, loss of appetite, dysphagia, pancreatitis, gingival hyperplasia, allergic reactions, burning sensation, rigidity, weight gain, weight loss, sexual dysfunction, abnormal dreams, dry mouth, hyperglycemia, thirst, leukopenia, purpura, thrombocytopenia, heart failure, irregular pulse, extrasystoles, skin depigmentation, dry skin, hair loss, muscle weakness, single contraction, dyscoordination, generalized muscle hypertonicity, moist cold skin, apathy, anxiety, amnesia, gastritis, increased appetite, loose stools, rhinitis, urinary disorders, polyuria, anosmia, taste distortion, abnormal ocular control, dry eyes, gynecomastia, jaundice, elevated liver enzyme levels, confusion, exfoliative dermatitis, Stevens-Johnson syndrome, photosensitivity reactions, toxic epidermal necrolysis, polyneuropathy, amnesia, peripheral neuropathy, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia and systemic symptom-associated drug reaction syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, headache, fatigue, elevated ALT, chest pain, elevated CK, constipation, elevated AST, numbness, sensory abnormalities, chest discomfort, nausea, abdominal pain, diarrhea, loss of appetite, abdominal bloating, syncope, generalized pain, muscle cramps, gout, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light, so it should be stored in a light-protective, closed container. Furthermore, it is advisable to keep the medication at room temperature between 1°C and 30°C. Storing it this way helps maintain the medication's effectiveness and safety.
Bright pink oval film-coated tablet
30 tablets (10 tablets x 3)/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Dae Won Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.